Grossman MH, Emanuel BS, Budarf ML (abril de 1992). «Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2». Genomics12 (4): 822-5. PMID1572656. doi:10.1016/0888-7543(92)90316-K.
Axelrod J (agosto de 1957). «O-Methylation of Epinephrine and Other Catechols in vitro and in vivo». Science126 (3270): 400-1. PMID13467217. doi:10.1126/science.126.3270.400.
Matsumoto, M (2003). «Catechol O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function». Neuroscience116: 127. doi:10.1016/S0306-4522(02)00556-0.
Karoum, Farouk; Chrapusta, Stanislaw J.; Egan, Michael F. (2002). «3-Methoxytyramine is the Major Metabolite of Released Dopamine in the Rat Frontal Cortex: Reassessment of the Effects of Antipsychotics on the Dynamics of Dopamine Release and Metabolism in the Frontal Cortex, Nucleus Accumbens, and Striatum by a Simple T». Journal of Neurochemistry63 (3): 972-9. PMID7914228. doi:10.1046/j.1471-4159.1994.63030972.x.
Ulmanen, Ismo; Peranen, Johan; Tenhunen, Jukka; Tilgmann, Carola; Karhunen, Tuula; Panula, Pertti; Bernasconi, Lilia; Aubry, Jean-Piere et al. (1997). «Expression and Intracellular Localization of Catechol O-methyltransferase in Transfected Mammalian Cells». European Journal of Biochemistry243 (1–2): 452-9. PMID9030772. doi:10.1111/j.1432-1033.1997.0452a.x.Se sugiere usar |número-autores= (ayuda)
Lotta T, Vidgren J, Tilgmann C, et al. (abril de 1995). «Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme». Biochemistry34 (13): 4202-10. PMID7703232. doi:10.1021/bi00013a008.
Lachman HM, Morrow B, Shprintzen R, et al. (1996). «Association of codon 108/158 catechol-o-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.». American Journal of Medical Genetics67 (5): 468-72. PMID8886163. doi:10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G.
Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM, Gilliam TC (diciembre de 2005). «Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations». Biol. Psychiatry58 (11): 901-7. PMID16043133. doi:10.1016/j.biopsych.2005.05.010.
Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (mayo de 2005). «Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction». Biol. Psychiatry57 (10): 1117-27. PMID15866551. doi:10.1016/j.biopsych.2005.01.026.
Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, Owen MJ (noviembre de 2007). «Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use». Br J Psychiatry191: 402-7. PMID17978319. doi:10.1192/bjp.bp.107.036129. Resumen divulgativo – MedWireNews.
Lelli-Chiesa G, Kempton MJ, Jogia J, et al. (abril de 2011). «The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives». Psychol Med41 (4): 779-88. PMID20667170. doi:10.1017/S0033291710001431.
Lelli-Chiesa G, Kempton MJ, Jogia J, Tatarelli R, Girardi P, Powell J, Collier DA, Frangou S (julio de 2010). «The impact of the Val158Met catechol- O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives». Psychol Med41 (4): 1-10. PMID20667170. doi:10.1017/S0033291710001431.
Kempton MJ, Haldane M, Jogia J, Christodoulou T, Powell J, Collier D, Williams SC, Frangou S (abril de 2009). «The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study». Int. J. Neuropsychopharmacol.12 (3): 371-81. PMID18796186. doi:10.1017/S1461145708009395.
Wichers M, Aguilera M, Kenis G, Krabbendam L, Myin-Germeys I, Jacobs N, Peeters F, Derom C, Vlietinck R, Mengelers R, Delespaul P, van Os J (diciembre de 2008). «The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life». Neuropsychopharmacology33 (13): 3030-6. PMID17687265. doi:10.1038/sj.npp.1301520.
Cairns, BE (2010 May). «Pathophysiology of TMD pain--basic mechanisms and their implications for pharmacotherapy». Journal of oral rehabilitation37 (6): 391-410. PMID20337865. doi:10.1111/j.1365-2842.2010.02074.x.
Bonifácio MJ, Palma PN, Almeida L, Soares-da-Silva P (2007). «Catechol-O-methyltransferase and its inhibitors in Parkinson's disease». CNS Drug Rev13 (3): 352-79. PMID17894650. doi:10.1111/j.1527-3458.2007.00020.x.
Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, Owen MJ (noviembre de 2007). «Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use». Br J Psychiatry191: 402-7. PMID17978319. doi:10.1192/bjp.bp.107.036129. Resumen divulgativo – MedWireNews.
nih.gov
ncbi.nlm.nih.gov
Grossman MH, Emanuel BS, Budarf ML (abril de 1992). «Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2». Genomics12 (4): 822-5. PMID1572656. doi:10.1016/0888-7543(92)90316-K.
Tai CH, Wu RM (febrero de 2002). «Catechol-O-methyltransferase and Parkinson's disease». Acta Med. Okayama56 (1): 1-6. PMID11873938.
Axelrod J (agosto de 1957). «O-Methylation of Epinephrine and Other Catechols in vitro and in vivo». Science126 (3270): 400-1. PMID13467217. doi:10.1126/science.126.3270.400.
Karoum, Farouk; Chrapusta, Stanislaw J.; Egan, Michael F. (2002). «3-Methoxytyramine is the Major Metabolite of Released Dopamine in the Rat Frontal Cortex: Reassessment of the Effects of Antipsychotics on the Dynamics of Dopamine Release and Metabolism in the Frontal Cortex, Nucleus Accumbens, and Striatum by a Simple T». Journal of Neurochemistry63 (3): 972-9. PMID7914228. doi:10.1046/j.1471-4159.1994.63030972.x.
Ulmanen, Ismo; Peranen, Johan; Tenhunen, Jukka; Tilgmann, Carola; Karhunen, Tuula; Panula, Pertti; Bernasconi, Lilia; Aubry, Jean-Piere et al. (1997). «Expression and Intracellular Localization of Catechol O-methyltransferase in Transfected Mammalian Cells». European Journal of Biochemistry243 (1–2): 452-9. PMID9030772. doi:10.1111/j.1432-1033.1997.0452a.x.Se sugiere usar |número-autores= (ayuda)
Lotta T, Vidgren J, Tilgmann C, et al. (abril de 1995). «Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme». Biochemistry34 (13): 4202-10. PMID7703232. doi:10.1021/bi00013a008.
Lachman HM, Morrow B, Shprintzen R, et al. (1996). «Association of codon 108/158 catechol-o-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.». American Journal of Medical Genetics67 (5): 468-72. PMID8886163. doi:10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G.
Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM, Gilliam TC (diciembre de 2005). «Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations». Biol. Psychiatry58 (11): 901-7. PMID16043133. doi:10.1016/j.biopsych.2005.05.010.
Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (mayo de 2005). «Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction». Biol. Psychiatry57 (10): 1117-27. PMID15866551. doi:10.1016/j.biopsych.2005.01.026.
Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, Owen MJ (noviembre de 2007). «Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use». Br J Psychiatry191: 402-7. PMID17978319. doi:10.1192/bjp.bp.107.036129. Resumen divulgativo – MedWireNews.
Lelli-Chiesa G, Kempton MJ, Jogia J, et al. (abril de 2011). «The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives». Psychol Med41 (4): 779-88. PMID20667170. doi:10.1017/S0033291710001431.
Lelli-Chiesa G, Kempton MJ, Jogia J, Tatarelli R, Girardi P, Powell J, Collier DA, Frangou S (julio de 2010). «The impact of the Val158Met catechol- O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives». Psychol Med41 (4): 1-10. PMID20667170. doi:10.1017/S0033291710001431.
Kempton MJ, Haldane M, Jogia J, Christodoulou T, Powell J, Collier D, Williams SC, Frangou S (abril de 2009). «The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study». Int. J. Neuropsychopharmacol.12 (3): 371-81. PMID18796186. doi:10.1017/S1461145708009395.
Wichers M, Aguilera M, Kenis G, Krabbendam L, Myin-Germeys I, Jacobs N, Peeters F, Derom C, Vlietinck R, Mengelers R, Delespaul P, van Os J (diciembre de 2008). «The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life». Neuropsychopharmacology33 (13): 3030-6. PMID17687265. doi:10.1038/sj.npp.1301520.
Cairns, BE (2010 May). «Pathophysiology of TMD pain--basic mechanisms and their implications for pharmacotherapy». Journal of oral rehabilitation37 (6): 391-410. PMID20337865. doi:10.1111/j.1365-2842.2010.02074.x.
Bonifácio MJ, Palma PN, Almeida L, Soares-da-Silva P (2007). «Catechol-O-methyltransferase and its inhibitors in Parkinson's disease». CNS Drug Rev13 (3): 352-79. PMID17894650. doi:10.1111/j.1527-3458.2007.00020.x.